Two groundbreaking studies have fundamentally challenged established paradigms of Alzheimer’s disease progression by revealing previously unrecognized mechanisms of neurodegeneration. First, researchers from Columbia University overturned long-held assumptions about the tau protein, discovering that it is produced locally in neuronal dendrites rather than migrating from axons as previously believed, suggesting that neurotoxic tau accumulation can originate directly at the synaptic level. Second, a concurrent study from Washington University in St. Louis demonstrated that the destructive immune response exacerbating brain damage is initiated outside the central nervous system; the harmful T-cells found in the brain are actually activated and instructed by peripheral dendritic cells located in lymph nodes and other extraneural tissues. Together, these paradigm-shifting discoveries identify localized dendritic tau production and peripheral immune system modulation as critical new drivers of Alzheimer’s pathology, significantly expanding our understanding of the disease and opening novel avenues for therapeutic intervention.
In healthy neurons, tau proteins are normally concentrated in axons, the long projections that transmit signals. In Alzheimer’s disease, tau accumulates in the cell body and dendrites and clumps together into filaments and tangles. The prevailing explanation has been that mature axonal tau detaches from microtubules and redistributes into these compartments. Many researchers are trying to find ways to block the travel of tau to prevent or treat the disease.
But the new study, published in Nature Neuroscience, proposes a very different explanation for tau’s presence in the dendrites: The proteins are born there.
Using a new imaging technique the researchers developed to pinpoint the birthplace of any protein (read more about the technique below), Ramachandran’s team found that tau proteins are synthesized solely in a neuron’s dendrites.
